Astrana Health, Inc.
ASTH
$40.81
$3.027.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 36.73% | 140.64% | 1,508.31% | -96.04% | 40.81% |
| Total Depreciation and Amortization | 0.45% | -5.62% | 5.16% | 125.93% | 0.79% |
| Total Amortization of Deferred Charges | 1.06% | -2.07% | 0.52% | 9.82% | 51.81% |
| Total Other Non-Cash Items | -63.10% | -17.69% | 54.32% | -40.62% | 34.02% |
| Change in Net Operating Assets | -128.57% | 167.53% | -153.94% | -125.92% | 843.83% |
| Cash from Operations | -51.88% | 2,458.14% | -128.99% | -89.05% | 446.71% |
| Capital Expenditure | 3.05% | -30.55% | -20.06% | -79.72% | 53.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 99.99% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.16% | -43.83% | -87.63% | 4,749.56% | -49.26% |
| Cash from Investing | -118.99% | -169.06% | 99.80% | -49,525.91% | 55.01% |
| Total Debt Issued | -- | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | -668.50% | -0.01% | 76.97% | -1,562.91% | 99.27% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 37.18% | 74.57% | -3,050.49% | 49.15% | 75.30% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 8.65% | 95.36% | -- | -- | 85.74% |
| Other Financing Activities | -5,100.53% | -95.16% | 156.41% | -85.38% | 79.74% |
| Cash from Financing | -552.09% | 39.40% | -104.06% | 7,607.42% | 80.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -257.46% | 262.66% | -124.42% | 52.71% | 371.19% |